VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 17 filers reported holding VANECK VECTORS ETF TR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $408,063 | -14.1% | 15,164 | -3.9% | 0.03% | -17.1% |
Q2 2023 | $475,090 | -6.3% | 15,778 | +0.7% | 0.04% | -12.8% |
Q1 2023 | $506,778 | +46.2% | 15,665 | +29.5% | 0.05% | +34.3% |
Q4 2022 | $346,653 | -30.0% | 12,095 | -41.2% | 0.04% | +25.0% |
Q3 2022 | $495,000 | +38.3% | 20,571 | +57.5% | 0.03% | +33.3% |
Q2 2022 | $358,000 | -32.8% | 13,061 | -6.1% | 0.02% | -19.2% |
Q1 2022 | $533,000 | +142.3% | 13,915 | +112.4% | 0.03% | +13.0% |
Q2 2021 | $220,000 | -36.8% | 6,552 | -26.2% | 0.02% | -59.6% |
Q3 2020 | $348,000 | +15.6% | 8,883 | +8.2% | 0.06% | +3.6% |
Q2 2020 | $301,000 | -65.2% | 8,208 | -78.1% | 0.06% | -72.2% |
Q1 2020 | $864,000 | -31.4% | 37,433 | -13.0% | 0.20% | +3.7% |
Q4 2019 | $1,260,000 | -38.2% | 43,034 | -43.7% | 0.19% | -55.0% |
Q3 2019 | $2,038,000 | +57.0% | 76,399 | +50.6% | 0.42% | +149.4% |
Q2 2019 | $1,298,000 | – | 50,720 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
Brown University | 541,096 | $19,490,000 | 14.10% |
Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |